Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2018, Article ID 5764187, 6 pages
https://doi.org/10.1155/2018/5764187
Research Article

Control of Cryptococcus Gattii Biofilms by an Ethanolic Extract of Cochlospermum Regium (Schrank) Pilger Leaves

1Faculdade de Medicina, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS 79070-900, Brazil
2Faculdade de Ciências Exatas e Tecnologia, Universidade Federal da Grande Dourados, Dourados, MS 79804-970, Brazil
3Faculdade de Ciências Biológicas e Ambientais, Universidade Federal da Grande Dourados, Dourados, MS 79804-970, Brazil
4Faculdade de Ciências da Saúde, Universidade Federal da Grande Dourados, Dourados, MS 79804-970, Brazil
5Departamento de Análise Clínicas e Biomedicina, Universidade Estadual de Maringá, Maringá, PR 87020-900, Brazil

Correspondence should be addressed to Adriana A. Almeida-Apolonio; moc.liamtoh@a.ojuaraa

Received 19 March 2018; Revised 22 April 2018; Accepted 8 May 2018; Published 6 June 2018

Academic Editor: Carlos H. G. Martins

Copyright © 2018 Adriana A. Almeida-Apolonio et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. A. D. F. De Aguiar, R. S. Pedroso, A. S. Borges, T. A. Moreira, L. B. de Araújo, and D. V. D. B. Röder, “The epidemiology of cryptococcosis and the characterization of Cryptococcus neoformans isolated in a Brazilian University Hospital,” Revista do Instituto de Medicina Tropical de São Paulo, vol. 95, no. e13, pp. 1–9, 2017. View at Google Scholar
  2. W. Fang, Z. Fa, and W. Liao, “Epidemiology of Cryptococcus and cryptococcosis in China,” Fungal Genetics and Biology, vol. 78, pp. 7–15, 2015. View at Publisher · View at Google Scholar
  3. J. Lizarazo, P. Escandón, C. I. N. Agudelo, C. Firacative, W. Meyer, and E. Castañeda, “Retrospective study of the epidemiology and clinical manifestations of Cryptococcus gattii infections in Colombia from 1997-2011,” PLOS Neglected Tropical Diseases, vol. 8, no. 11, p. e3272, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. Z.-R. Tan, X.-Y. Long, G.-L. Li, J.-X. Zhou, and L. Long, “Spectrum of neuroimaging findings in cryptococcal meningitis in immunocompetent patients in China — A series of 18 cases,” Journal of the Neurological Sciences, vol. 368, pp. 132–137, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Armstrong-James, G. Meintjes, and G. D. Brown, “A neglected epidemic: Fungal infections in HIV/AIDS,” Trends in Microbiology, vol. 22, no. 3, pp. 120–127, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. S. F. Molloy, T. Chiller, G. S. Greene et al., “Cryptococcal meningitis: A neglected NTD?” PLOS Neglected Tropical Diseases, vol. 11, no. 6, Article ID e0005575, 2017. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Coelho and A. Casadevall, “Cryptococcal therapies and drug targets: the old, the new and the promising,” Cellular Microbiology, vol. 18, no. 6, pp. 792–799, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. K. J. Kwon-Chung, J. E. Bennett, B. L. Wickes et al., “The Case for Adopting the “Species Complex” Nomenclature for the Etiologic Agents of Cryptococcosis,” mSphere, vol. 2, no. 1, p. e00357-16, 2017. View at Publisher · View at Google Scholar
  9. C. Franco-Paredes, T. Womack, T. Bohlmeyer et al., “Management of Cryptococcus gattii meningoencephalitis,” The Lancet Infectious Diseases, vol. 15, no. 3, pp. 348–355, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. S. C.-A. Chen, W. Meyer, and T. C. Sorrell, “Cryptococcus gattii infections,” Clinical Microbiology Reviews, vol. 27, no. 4, pp. 980–1024, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Samantaray, J. N. Correia, M. Garelnabi, K. Voelz, R. C. May, and R. A. Hall, “Novel cell-based in vitro screen to identify small-molecule inhibitors against intracellular replication of Cryptococcus neoformans in macrophages,” International Journal of Antimicrobial Agents, vol. 48, no. 1, pp. 69–77, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Varma and K. J. Kwon-Chung, “Heteroresistance of Cryptococcus gattii to fluconazole,” Antimicrobial Agents and Chemotherapy, vol. 54, no. 6, pp. 2303–2311, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Laniado-Laborín and M. N. Cabrales-Vargas, “Amphotericin B: side effects and toxicity,” Revista Iberoamericana de Micología, vol. 26, no. 4, pp. 223–227, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. P. R. Williamson, J. N. Jarvis, A. A. Panackal et al., “Cryptococcal meningitis: Epidemiology, immunology, diagnosis and therapy,” Nature Reviews Neurology, vol. 13, no. 1, pp. 13–24, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. N. T. Grossman and A. Casadevall, “Physiological differences in Cryptococcus neoformans strains in vitro versus in vivo and their effects on antifungal susceptibility,” Antimicrobial Agents and Chemotherapy, vol. 61, no. 3, Article ID e02108-16, 2017. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Aslanyan, D. Sanchez, S. Valdebenito, E. Eugenin, R. Ramos, and L. Martinez, “The Crucial Role of Biofilms in Cryptococcus neoformans Survival within Macrophages and Colonization of the Central Nervous System,” Journal of Fungi, vol. 3, no. 1, p. 10, 2017. View at Publisher · View at Google Scholar
  17. P. Kumari, R. Mishra, N. Arora et al., “Antifungal and anti-biofilm activity of essential oil active components against Cryptococcus neoformans and Cryptococcus laurentii,” Frontiers in Microbiology, vol. 8, article no. 2161, 2017. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Sólon, L. F. G. Brandão, and J. M. Siqueira, “Kunth com ênfase nos aspectos etnobotânicos, farmacológicos, toxicológicos e químicos de Cochlospermum regium (Mart. et. Schr.) Pilger,” Revista Eletrônica de Farmácia, vol. 6, no. 3, 2009. View at Publisher · View at Google Scholar
  19. M. C. Inácio, T. A. Paz, B. W. Bertoni, M. A. R. Vieira, M. O. M. Marques, and A. M. S. Pereira, “Histochemical investigation of Cochlospermum regium (Schrank) Pilg. leaves and chemical composition of its essential oil,” Natural Product Research (Formerly Natural Product Letters), vol. 28, no. 10, pp. 727–731, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Solon, C. A. Carollo, L. F. G. Brandão et al., “Phenolic derivatives and other chemical compounds from,” Química Nova, vol. 35, no. 6, pp. 1169–1172, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. F. L. B. Mügge, J. Paula-Souza, J. C. Melo, and M. G. L. Brandão, “Native plant species with economic value from Minas Gerais and Goiás: a discussion on the currentness of the data recovered by the French naturalist auguste de saint-hilaire,” Horticultura Brasileira, vol. 34, no. 4, pp. 455–462, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. D. E. Leme, A. B. Rodrigues, A. A. Almeida-Apolonio et al., “In vitro control of uropathogenic microorganisms with the ethanolic extract from the leaves of Cochlospermum regium (Schrank) Pilger,” Evidence-Based Complementary and Alternative Medicine, vol. 2017, pp. 1–8, 2017. View at Publisher · View at Google Scholar
  23. Clinical and Laboratory Standards Institute (CLSI), Reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard M27-A3, Clinical and Laboratory Standards Institute, Wayne, Pa, USA, 2008.
  24. R. E. Lewis, D. J. Diekema, S. A. Messer, M. A. Pfaller, and M. E. Klepser, “Comparison of Etest, chequerboard dilution and time-kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species,” Journal of Antimicrobial Chemotherapy, vol. 49, no. 2, pp. 345–351, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. L. R. Martinez and A. Casadevall, “Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro,” Antimicrobial Agents and Chemotherapy, vol. 50, no. 3, pp. 1021–1033, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Donegan, C. Matyac, R. Seidler, and A. Porteous, “Evaluation of methods for sampling, recovery, and enumeration of bacteria applied to the phylloplane,” Applied and Environmental Microbiology, vol. 57, no. 1, pp. 51–56, 1991. View at Google Scholar · View at Scopus
  27. D. Monteiro, S. Silva, M. Negri et al., “Silver nanoparticles: influence of stabilizing agent and diameter on antifungal activity against Candida albicans and Candida glabrata biofilms,” Letters in Applied Microbiology, vol. 54, no. 5, pp. 383–391, 2012. View at Publisher · View at Google Scholar
  28. J. R. A. Santos, L. F. Gouveia, E. L. S. Taylor et al., “Dynamic interaction between fluconazole and amphotericin B against Cryptococcus gattii,” Antimicrobial Agents and Chemotherapy, vol. 56, no. 5, pp. 2553–2558, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Benaducci, J. D. C. O. Sardi, N. M. S. Lourencetti et al., “Virulence of Cryptococcus sp. biofilms in vitro and in vivo using Galleria mellonella as an alternative model,” Frontiers in Microbiology, vol. 7, article no. 290, 2016. View at Publisher · View at Google Scholar · View at Scopus
  30. G. Morales, A. Paredes, P. Sierra, and L. A. Loyola, “Antimicrobial activity of three Baccharis species used in the traditional medicine of Northern Chile,” Molecules, vol. 13, no. 4, pp. 790–794, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. G. Ramage, R. Rajendran, L. Sherry, and C. Williams, “Fungal biofilm resistance,” International Journal of Microbiology, vol. 2012, Article ID 528521, 14 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. L. R. Martinez and A. Casadevall, “Specific antibody can prevent fungal biofilm formation and this effect correlates with protective efficacy,” Infection and Immunity, vol. 73, no. 10, pp. 6350–6362, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Genebat, M. J. Mayorga-Buiza, E. Castillo-Ojeda, M. Rivero-Garvía, F. J. Márquez-Rivas, and M. E. Jiménez-Mejías, “Cryptococcal Infection of the Ventriculoperitoneal Shunt in an HIV-Infected Patient with an Excellent Immunovirologic Status,” World Neurosurgery, vol. 99, pp. 810–810.e13, 2017. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Negri, S. Silva, I. R. G. Capoci, J. Azeredo, and M. Henriques, “Candida tropicalis Biofilms: Biomass, Metabolic Activity and Secreted Aspartyl Proteinase Production,” Mycopathologia, vol. 181, no. 3-4, pp. 217–224, 2016. View at Publisher · View at Google Scholar · View at Scopus
  35. W. J. Cupozak-Pinheiro, Atividade antibiofilme do extrato etanólico das folhas de Cochlospermum regium (Mart & Schrank) Pilger (Bixaceae) contra Cryptococcus gattii, Completion of course work, Universidade Federal da Grande Dourados, 2017.
  36. V. M. Berres, Investigação da potencial atividade antifúngica de Cochlospermum regium (Mart Schrank) Pilger (Bixaceae) e sua combinação com fluconazol frentea Cryptococcus gattii, Completion of course work, Universidade Federal da Grande Dourados, 2017.